Drupal.behaviors.print = function(context) {window.print();window.close();}>
Myriad Plans NGS-Based Tests, Says Whole-Genome Sequencing Not Yet Ready for Clinical Use
January 04, 2012
Myriad Plans NGS-Based Tests, Says Whole-Genome Sequencing Not Yet Ready for Clinical Use
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Myriad Partners with RainDance for Front End of NGS-based Hereditary Cancer Panel Test
April 17, 2013 / Clinical Sequencing News
Asuragen Launches Cancer Panels Optimized for FFPE Tissue; Plans to Sell Proprietary Reagents
April 10, 2013 / Clinical Sequencing News
Oxford Group Launches PGM-Based Cancer Test under UK's Stratified Medicine Program
January 2, 2013 / Clinical Sequencing News
Cancer Sequencing Takes off in 2011 Amid Debate on Benefits of Targeted vs. Comprehensive Approaches
January 11, 2012 / Clinical Sequencing News
Uppsala Team's ProteinSeq Assay Combines PLA and Next-Gen Sequencing for Protein Detection
October 7, 2011 / ProteoMonitor